Home |Register |Login |Company Information
Our Company
Order Publications
Advertisers
Customer Service
|Survey |Help
Search MPR Database:

The most widely used drug reference by clinicians
Therapeutic Categories Brand Generic Manufacturer News
Drug News
New Products
Resources
Alerts (Sponsored)
Clinical Charts
Prescribing Notes
Manufacturer Index
empr Download We've Got Answers

New Product Releases

July 3, 2008
  • Lexiscan
June 27, 2008
  • Entereg
June 20, 2008
  • Relistor
June 12, 2008
  • Ferralet 90
June 6, 2008
  • Cimzia
May 30, 2008
  • Treximet
May 22, 2008
  • Patanase
May 16, 2008
  • Treanda
May 9, 2008
  • Omnaris
May 2, 2008
  • Pristiq
April 25, 2008
  • Evamist
April 17, 2008
  • Arcalyst
April 11, 2008
  • Totect
April 4, 2008
  • Simcor 500/20
March 27, 2008
  • Triesence
March 21, 2008
  • Renvela
March 14, 2008
  • » Ibudone 5/200
March 7, 2008
  • Intelence
February 29, 2008
  • Tekturna HCT 150/12.5
February 21, 2008
  • Flector Patch
February 14, 2008
  • Fosteum
February 7, 2008
  • Recothrom
January 31, 2008
  • Voltaren Gel
January 25, 2008
  • Veregen
January 17, 2008
  • Bystolic
January 10, 2008
  • Kuvan
January 4, 2008
  • Calomist
December 27, 2007
  • Combigan
December 20, 2007
  • Tasigna
December 13, 2007
  • Ixempra
December 6, 2007
  • Isentress
November 29, 2007
  • Doribax
November 21, 2007
  • Afluria
November 15, 2007
  • Torisel
November 8, 2007
  • Endometrin
November 1, 2007
  • Azor
September 25, 2007
  • Perforomist
  • Selzentry
  • Xyzal
August 24, 2007
  • Azasite
August 1, 2007
  • Divigel
  • Exforge 5/160
  • Lybrel
June 27, 2007
  • Neupro
  • Pylera
  • Symbicort 160/4.5
  • Vyvanse
May 25, 2007
  • Altabax
  • Elestrin
  • Reclast
  • Veramyst
May 7, 2007
  • Tykerb
May 2, 2007
  • Fexmid
  • Janumet
March 28, 2007
  • Brovana
  • Tekturna
February 21, 2007
  • Implanon
  • Lialda
January 31, 2007
  • Invega
  • Pataday
January 4, 2007
  • Angeliq
  • Tyzeka
  • Ziana
Archived Products »

IBUDONE 5/200 CIII

Company:

ProEthic

Pharmacologic class:

Narcotic analgesic (opioid + NSAID)

Active ingredient:

Hydrocodone bitartrate 5mg, ibuprofen 200mg; tabs.

ALSO:

Ibudone 10/200

Active ingredient:

Hydrocodone bitartrate 10mg, ibuprofen 200mg; tabs.

Indication:

Short term (generally less than 10 days) management of acute pain.

Pharmacology:

Ibudone combines the opioid analgesic, hydrocodone, with the non-steroidal antiinflammatory drug (NSAID), ibuprofen. Hydrocodone is a semi-synthetic codeine derivative with analgesic, antitussive, and CNS effects. Ibuprofen is an antiinflammatory agent with antipyretic and analgesic effects as well.

This product is indicated only for the treatment of acute pain; it is not indicated for treating chronic conditions such as arthritis.

Clinical trials:

Hydrocodone and ibuprofen tablets were shown to be more effective than placebo and each of the individual components in the treatment of postsurgical pain. In a clinical trial involving 940 patients who had undergone abdominal, gynecological, or orthopedic surgery, single doses of one or two tablets were evaluated. The two-tablet dose was not found to be superior to the one-tablet dose.

Adults:

Individualize; use lowest effective dose for shortest time. ≥16yrs: 1 tab every 4–6 hours as needed; max 5 tabs/day.

Children:

<16yrs: not recommended.

Contraindications:

Aspirin allergy. Coronary artery bypass graft surgery. 3rd trimester pregnancy.

Precautions:

Advanced renal disease: not recommended. Head injury. Increased intracranial pressure. Acute abdomen. Peptic ulcer. History of upper GI disease. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. GI or GU obstruction. Asthma. Edema. Hypertension. Heart failure. Bleeding disorders. Monitor BP, blood, and hepatic and renal function. Dehydration. Post-op (may suppress cough reflex). Drug abusers. Discontinue if hepatic dysfunction occurs. Elderly. Debilitated. Pregnancy (Cat.C). Labor & delivery, nursing mothers: not recommended.

Interactions:

See Contraindications. Avoid aspirin. Alcohol, other CNS depressants potentiated. May potentiate, or be potentiated by, MAOIs (not recommended) or tricyclic antidepressants, skeletal muscle relaxants. Increases serum lithium levels. May reduce efficacy of, and increase risk of renal failure with, ACEIs, diuretics. May increase bleeding with anticoagulants. Paralytic ileus may occur with anticholinergics. May increase lithium, methotrexate toxicity. Corticosteroids increase risk of GI bleed.

Adverse reactions:

Headache, CNS depression, dizziness, GI upset/bleed, constipation, rash (discontinue if occurs), respiratory depression, anemia, mood changes, confusion, anaphylaxis; aseptic meningitis (rare); others. See literature re: risk of cardiovascular events.

How supplied:

Tabs—100

Last Updated:

3/14/08

From Haymarket Media, Inc. the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living
HonCode
© Copyright 2008 | All Rights Reserved. | Disclaimer | Privacy Policy | Site Map | Print Subscription Questions | Online Acct. Help | Subscribe
Haymarket Publishing